Revoc (Risperidone) is a novel antipsychotic belonging to a new class of antipsychotic agents, the benezisoxazole-derivatives.
Revoc is indicated for the treatment of acute and chronic schizophrenic psychoses, and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness) and/or negative symptoms (such as blunted affect, emotional and social withdrawal, poverty of speech) are prominent. Revoc also alleviates affective symptoms (such as depression, guilt feelings, anxiety) associated with schizophrenia.
Revoc is also indicated as long-term therapy for the prevention of relapse (acute exacerbations) in chronic schizophrenic patients.
In addition, Revoc is indicated for the treatment of behavioral disturbances in patients with dementia in whom symptoms such as aggressiveness (verbal outbursts, physical violence), activity disturbances (agitation, wandering) or psychotic symptoms are prominent.
Explore more products from our portfolio
